Venetoclax and Decitabine in R/R T-ALL
Venetoclax and Decitabine in R/R T-ALL
Recruiting · NCT06712121 · Registry updated 2026-02-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Venetoclax and Decitabine in R/R T-ALL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T lymphoblastic leukemia/lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-02-02 | NCT06712121 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Korean Society of Hematology | 3 |
| Seoul National University Hospital | 277 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Seoul National University Bundang Hospital | Seongnam-si | South Korea | 57 |
| Seoul National University Hospital | Seoul | South Korea | 393 |